Skip to product information
1 of 1

Humana

Leukemia and Lymphoma: Detection of Minimal Residual Disease

Leukemia and Lymphoma: Detection of Minimal Residual Disease

Regular price $183.99 USD
Regular price Sale price $183.99 USD
Sale Sold out
Shipping calculated at checkout.
Format
In Leukemia and Lymphoma: Detection of Minimal Residual Disease, hands-on experts describe and discuss the minimal residual disease (MRD) methods they have successfully pioneered for leukemias and lymphomas. They apply reverse transcription PCR (RT-PCR) to acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), and acute promyelocytic leukemia (APL). Other PCR methods are used for Non-Hodgkin's Lymphoma and for the monitoring of follicular lymphoma. Additional chapters address the use of real-time quantitative PCR (RQ-PCR), the emergent method of choice, in patients with acute lymphoblastic leukemia (ALL), the evaluation of MRD techniques in clinical trials, and the application of flow cytometry techniques.

Author: Theodore F. Zipf
Publisher: Humana
Published: 10/21/2002
Pages: 257
Binding Type: Hardcover
Weight: 1.38lbs
Size: 9.26h x 6.12w x 0.95d
ISBN: 9780896039667
View full details